Therefore, to investigate whether the activation of SIRT1 could attenuate hyperlipidemia-induced cardiac fibrosis in vivo and whether the TGF-β/Smad pathway is involved in this process, Masson’s trichrome staining and collagen III, TGF-β, and Smad3 expression were assessed. Here, SMAD3 is linked to hyperlipidemia.